Figures & data
Figure 1. Renal outcomes according to different definitions. rAKI, recovered AKI; crAKI, complete-recovered AKI; nrAKI, non-recovered AKI; ncrAKI, non-complete recovered AKI.
Table 1. Demographic, clinical characteristics and blood chemistry data at baseline.
Table 2. Clinical features between different groups with recovered AKI and non-recovered AKI.
Table 3. Clinical features between groups with completely recovered AKI and non-completely recovered AKI.
Figure 2. Kinetics of AOPP level in different groups. AOPP levels at baseline, days 2 and days 7 after surgery in controls, patients with recovered AKI and patients with non-recovered AKI (a) or in controls, patients with completely recovered AKI and patients with non-completely recovered AKI (b). rAKI, recovered AKI; crAKI, complete-recovered AKI; nrAKI, non-recovered AKI; ncrAKI, non-completely recovered AKI. *p < .05 AOPP level between patients with nrAKI and controls. #p < .05 AOPP level between patients with nrAKI and patients with rAKI. †p < .05 AOPP level between the baseline and at 7 days in the patients with nrAKI. ‡p < .05 AOPP level between patients with ncrAKI and controls. §p < .05 AOPP level between patients with ncrAKI and patients with crAKI. ¶p < .05 AOPP level between the baseline and at 7 days in the patients with ncrAKI.
Table 4. Relationship between AOPP level at 7 days and clinical indices.
Table 5. AOPP as risk factors for adverse outcomes of AKI recovery.
Table 6. Predictive performances of serum AOPP at day 7 for adverse outcomes of AKI recovery.